Article ISI
JOURNAL OF CLINICAL ONCOLOGY  (2021)

First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649.

Moehler, Markus H.; Shitara, Kohei; Garrido, Marcelo; Salman, Pamela; Shen, Lin; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Bragagnoli, Arinilda Silva Campos; Liu, Tianshu; Schenker, Michael; Yanez, Patricio Eduardo; Tehfe, Mustapha; Li, Mingshun; Cullen, Dana; et. al.